Treatment-independent miRNA signature in blood of wilms tumor patients

BACKGROUND: Blood-born miRNA signatures have recently been reported for various tumor diseases. Here, we compared the miRNA signature in Wilms tumor patients prior and after preoperative chemotherapy according to SIOP protocol 2001. RESULTS: We did not find a significant difference between miRNA sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt, Jana, Backes, Christina, Nourkami-Tutdibi, Nasenien, Leidinger, Petra, Deutscher, Stephanie, Beier, Markus, Gessler, Manfred, Graf, Norbert, Lenhof, Hans-Peter, Keller, Andreas, Meese, Eckart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563587/
https://www.ncbi.nlm.nih.gov/pubmed/22871070
http://dx.doi.org/10.1186/1471-2164-13-379
Descripción
Sumario:BACKGROUND: Blood-born miRNA signatures have recently been reported for various tumor diseases. Here, we compared the miRNA signature in Wilms tumor patients prior and after preoperative chemotherapy according to SIOP protocol 2001. RESULTS: We did not find a significant difference between miRNA signature of both groups. However both, Wilms tumor patients prior and after chemotherapy showed a miRNA signature different from healthy controls. The signature of Wilms tumor patients prior to chemotherapy showed an accuracy of 97.5% and of patients after chemotherapy an accuracy of 97.0%, each as compared to healthy controls. CONCLUSION: Our results provide evidence for a blood-born Wilms tumor miRNA signature largely independent of four weeks preoperative chemotherapy treatment.

Ejemplares similares